AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
11.12
-1.15 (-9.37%)
At close: Nov 2, 2026, 4:00 PM EST
11.18
+0.06 (0.54%)
After-hours: Nov 2, 2026, 7:55 PM EST
AbCellera Biologics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Initiates $21 | Buy | Initiates | $21 | +88.85% | Oct 30, 2026 |
| UBS | UBS | Buy Initiates $18 | Buy | Initiates | $18 | +61.87% | Oct 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $17 | Buy | Initiates | $17 | +52.88% | Sep 29, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $13 → $25 | Buy | Reiterates | $13 → $25 | +124.82% | Sep 27, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $13 | Hold | Initiates | $13 | +16.91% | Sep 24, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $30 | Buy | Reiterates | $30 | +169.78% | Sep 2, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $15 | Buy | Maintains | $15 | +34.89% | Aug 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 | Buy | Maintains | $12 | +7.91% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.